Please login to the form below

Not currently logged in

The inVentiv Health Communications Award for Excellence in Healthcare Collaboration and Partnerships

Sponsored by

Back to Results


Addressing the Base of the Pyramid

by Novo Nordisk A/S with support from Lagos State Government, General Hospital Ikorodu and Sunny Kuku Foundation

Summary of work

In Nigeria, where healthcare services and accessibility are poor, diabetes exerts a high burden of disease. The lack of adequate doctor training in initiating and managing diabetes treatment is a major barrier to insulin use. Some public hospitals run diabetes clinics which attract large numbers of diabetes patients, but as a consequence of lack of time and resources, no personalised care is available, leading to ineffective insulin initiation and compliance. In addition, insulin is often sold to patients with excessive margins, making this essential drug unaffordable for the majority.

In order to overcome these barriers, Novo Nordisk has partnered with the largest secondary care hospital of Lagos State, General Hospital Ikorodu (GHI), a diabetes association (the Sunny Kuku foundation) and a blood glucose test provider (Roche) to create a one-stop-shop Diabetes Support Centre in the heart of the GHI. The Base of Pyramid initiative is making insulin available at the point of prescription as well as training diabetes educators to provide the necessary treatment information and improve compliance.

Patients are referred to the Diabetes Support Centre by the prescribers where personalised care, diabetes education and diabetes drugs are available, including insulin at a transparent and capped price.

Judges comments

There was undoubtedly good collaboration and true partnership here. The customer need was carefully identified, objectives were clearly defined and they have set up a fantastic baseline of the number of patients treated. However, as yet, it’s too early for us to see substantial evidence of real outcomes and so we look forward with interest to seeing this again in 2014.


Maintaining Adherence Programme - by Janssen with support from Havas Lynx


Improving Anaphylaxis Treatment – A North West Initiative - by ALK-Abelló Ltd

The London Joint Working Group on Substance Misuse and Hepatitis C (LJWG) - by LJWG with support from Dovetail Strategies funded by: Janssen, MSD, Reckitt Benckiser Pharmaceuticals, and Roche Products

Addressing the Base of the Pyramid - by Novo Nordisk A/S with support from Lagos State Government, General Hospital Ikorodu and Sunny Kuku Foundation

Helping foster an unlikely partnership between Endocrinologists and Nephrologists: the European Hyponatraemia Network (EHN) - by Otsuka Pharmaceutical Europe Ltd. with support from Apothecom, a Huntsworth Health Company

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022